Financial Services
Live Price
Offline$0.02
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 โ Jun 17, 2026
Coverage: 248 bars ยท Jun 23, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tanke Biosciences Corporation (TNBI) is a Financial Services stock with listed on OTC. The stock last traded around $0.02 and up 0.0% across the available one-year price window (Jun 23, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -129.8%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -129.8%, free cash flow -6.0% with operating margin -3038.1% and ROIC 99.0%. Valuation already assumes a fairly strong business story at price/sales 100.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TNBI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +3.4% peer median
Operating Margin
Below sector median
-3038.1% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2023 was reported on Dec 31, 2023, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at 0.0% and EPS is at -129.8%, with operating margin around -3038.1%.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TNBI
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
TNBI Max Drawdown
-66.67%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for TNBI and SPY.

Company Overview
Tanke Biosciences Corporation
Other OTC
Tanke Biosciences Corporation, through its subsidiaries, develops, produces, markets, and sells animal nutrition and feed additive products. It operates in four segments: Organic Trace Mineral Additives, Functional Regulation Additives, Herbal Medicinal Additives, and Other. The company offers organic trace mineral additives under the Qili brand name; feed acidifiers, which are used to prevent microbial degradation of raw materials or finished feeds under the Qilicid name; seasonings; flavor enhancers that are used as the agent in the production of blended feed under the Tankeball name; and herbal medicinal additives blended with feed products under the Extra-Health, Qilimix, and Recoccider names. It also produces and markets multiple trace mineral premix products for livestock and poultry under the Qilimix name. In addition, the company provides natural sweeteners and attractants for use with feed for pigs, piglets, fish, and other aquatic animals under the Tankeball name; and water soluble organic multi-vitamin electrolyte, which is fed to animals through dissolving it in drinking water for the animals to consume. It serves mid-to-large sized feed product factories, large scale feed producers, and farmers. The company sells its products primarily in the People's Republic of China, Southeast Asia, and Latin America. Tanke Biosciences Corporation was founded in 1989 and is headquartered in Guangzhou, the People's Republic of China.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.